6d
HEALTH CANADA AUTHORIZES LILLY'S KISUNLA™ (DONANEMAB), A NEW TREATMENT FOR EARLY ALZHEIMER'S DISEASE
CNW/ - Today, after more than 35 years of commitment to advancing Alzheimer's research, Lilly Canada announced Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results